English
Structure via PubChem · Public domain (PubChem)
(+)-emtricitabine
Sign in to saveRacivir is an experimental nucleoside reverse transcriptase inhibitor (NRTI), developed by Pharmasset for the treatment of HIV. It is the enantiomer of emtricitabine, a widely used NRTI, meaning that the two compounds are mirror images of each other.
In the Vinony graph
Vinony's link graph records 127 inbound references to (+)-emtricitabine, and connects out to tenofovir alafenamide, reverse-transcriptase inhibitor and nucleoside analogue.
It sits within the topics Chemical pages without DrugBank identifier, Drugs not assigned an ATC code and Drugs with no legal status.
Vinony links it to 5 Wikipedia language editions.
Chemical data
- Formula
- C8H10FN3O3S
- Molecular weight
- 247.25 g/mol
- IUPAC name
- 4-amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
- SMILES
- C1[C@@H](O[C@@H](S1)CO)N2C=C(C(=NC2=O)N)F
- InChIKey
- XQSPYNMVSIKCOC-RITPCOANSA-N
- XLogP
- -0.6
- Polar surface area
- 113 Ų
- H-bond donors
- 2
- H-bond acceptors
- 5
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Molecule type
- Small molecule
via ChEMBL · EBI
Wikidata facts
- Mass
- 247.043
Show 4 more facts
- chemical formula
- C₈H₁₀FN₃O₃S
- canonical SMILES
- C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
- isomeric SMILES
- C1[C@@H](O[C@@H](S1)CO)N2C=C(C(=NC2=O)N)F
- Commons category
- Racivir
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Racivir is an experimental nucleoside reverse transcriptase inhibitor (NRTI), developed by Pharmasset for the treatment of HIV. It is the enantiomer of emtricitabine, a widely used NRTI, meaning that the two compounds are mirror images of each other.
thumb|left|Emtricitabine, the [[enantiomer of racivir and a widely used NRTI]]
Excerpted from Wikipedia’s “(+)-emtricitabine” article, available under the CC BY-SA 4.0 licence.